Justin Ryder
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease (NCT03867487) | Justin Ryder | 2027-05-01 |
| Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease (NCT06355310) | Justin Ryder | 2025-04-10 |
Track Justin Ryder automatically
Every clearance here is in the API, with alerts when new ones post.